Although no significant correlation was observed between IDO1 DNA promoter methylation and patient characteristics, we found that HNSCC samples have significantly lower IDO1 promoter methylation levels than normal tissues. The gene discussed is IDO1; the disease is head and neck squamous cell carcinoma.